The Weill Cancer Hub East brings together experts from the four institutions to improve immunotherapy, a therapeutic strategy ...

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to LX9851, an ...

Scientists created transgenic mice with woolly mammoth–like traits. But does it really bring us closer to bringing back woolly mammoths?

Mitolyn's effectiveness has sparked greater interest in research on mitochondrial health as an essential component of weight ...

A small lemur native to Madagascar may hold unexpected clues to reversing aging, thanks to a surprising cellular ability ...

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has entered into an exclusive license agreement with Novo Nordisk A/S for ...

REGIONS NEWS Lexicon eligible to receive up to $1 billion in upfront and development, regulatory and sales milestone payments, including $75 million in upfront and near-term milestone payments ...